Danske Bank’s Biomerica BMRA Stock Holding History

Danske Bank’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2	Hold	1	–	–	﹤0.01%	1136
2025 Q4	$3	Hold	1	–	–	﹤0.01%	1522
2025 Q3	$3	Hold	1	–	–	﹤0.01%	1451
2025 Q2	$3	Buy	+1	New	+$4	﹤0.01%	1486

Other funds holding BMRA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Danske Bank's BMRA Position: Q1 2026 in Review

Danske Bank held its Biomerica (BMRA) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Danske Bank first reported a position in BMRA in Q2 2025 and has held it in 4 quarters since. The position peaked at $3 in Q4 2025. 11 funds tracked by Wall St. Rank hold BMRA as of Q1 2026.

Danske Bank held 1 share of Biomerica worth $2 as of Q1 2026.
Danske Bank left its Biomerica share count unchanged in Q1 2026.
Biomerica made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1136 holding.
Danske Bank first reported a position in Biomerica in Q2 2025 and has held it in 4 quarters since.
Danske Bank's Biomerica position peaked at $3 in Q4 2025.
11 funds tracked by Wall St. Rank held Biomerica as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.